Search

Your search keyword '"Sieper, Joachim"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Sieper, Joachim" Remove constraint Author: "Sieper, Joachim" Publisher elsevier Remove constraint Publisher: elsevier
35 results on '"Sieper, Joachim"'

Search Results

1. List of Contributors

3. List of Contributors

6. Contributors

7. List of Contributors

10. Contributors

11. Knochen und Gelenke

12. Autorinnen und Autoren

14. Contributors

15. Contributors

19. Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial.

20. Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial.

21. Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.

22. Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study.

23. What low back pain is and why we need to pay attention.

24. Peripheral spondyloarthritis: Concept, diagnosis and treatment.

25. Axial spondyloarthritis.

26. Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.

27. How important is early therapy in axial spondyloarthritis?

28. Classification, diagnosis, and referral of patients with axial spondyloarthritis.

30. Investigation of involved tissue in axial spondyloarthritis--what have we learnt from immunohistochemical studies?

31. Cytokine-induced human IFN-gamma-secreting effector-memory Th cells in chronic autoimmune inflammation.

32. Ankylosing spondylitis.

33. Concepts and epidemiology of spondyloarthritis.

34. Identification of HLA-B27-restricted peptides in reactive arthritis and other spondyloarthropathies: computer algorithms and fluorescent activated cell sorting analysis as tools for hunting of HLA-B27-restricted chlamydial and autologous crossreactive peptides involved in reactive arthritis and ankylosing spondylitis.

35. Prevalence and molecular diversity of pHS-2 plasmids, marker for arthritogenicity, among clinical Escherichia coli Shigella isolates.

Catalog

Books, media, physical & digital resources